Microglial stability and repopulation in the retina
- Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
- Correspondence to: Narsing A Rao Doheny Eye Institute, DVRC 211, 1450 San Pablo Street, Los Angeles, CA 90033, USA; nraousc.edu
- Accepted 14 December 2004
Abstract
Background/aims: Parenchymal central nervous system microglia are repopulated by bone marrow derived monocytes more slowly than any other reticuloendothelial cells. The contribution of bone marrow derived monocytes to the uninflammed retina has not been studied. The present study sought to determine repopulation of retinal microglia in uniflammed retina by bone marrow derived monocytes in bone marrow chimeric rats.
Methods: Chimeric (Y→X) Lewis rats were constructed by transplanting 5×107 male bone marrow cells into lethally irradiated female recipient rats. The chimeras were sacrificed 8, 10, 12, 30, and 52 weeks after bone marrow transplant, and retina, brain, lung, and spleen samples were collected. DNA was extracted and quantified. Y positive infiltrating cells in the collected samples were detected by polymerase chain reaction amplification of a Y chromosome specific 104 bp fragment.
Results: There was a rapid repopulation of haematopoietic tissues in the spleen (at 8 weeks), confirming the establishment of chimerism, and to a lesser extent, of lung (at 30 weeks). This repopulation was absent in the brain parenchyma and retina until 52 weeks after transplantation.
Conclusions: These data indicate that resident microglia in the retina, much like those in the brain, are stable in number in the retinal compartment (up to 1 year), and repopulation by bone marrow derived cells may be delayed for a year.
- CNS, central nervous system
- EAU, experimental autoimmune uveitis
- transplant chimera
- bone marrow transplant
- sry gene
- retina
- CNS, central nervous system
- EAU, experimental autoimmune uveitis
- transplant chimera
- bone marrow transplant
- sry gene
- retina
Footnotes
-
Supported in part by National Eye Institute Grant EY013253 and core grant 3040 from the National Institutes of Health, Bethesda, Maryland, and unrestistricted grant from Research to Prevent Blindness, New York, NY, USA.
